Evidence map›Paper›PMID 32685911›Full record

ArticleRheumatology advances in practice2020

Use of rheumatoid arthritis impact of disease (RAID) in routine care; identification of DAS28 remission and unmet patient-reported outcomes.

Jatin Mistry, Mohammed Sharif, Amy Prideaux, Catherine Smith, Malama Sumbwanyambe, Margaret Sibley, Lewis Carpenter, Melissa Sweeney, Patrick Kiely

Open access · goldAbstract read
In one paragraph

Article in Rheumatology advances in practice, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 2 pooled it
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 2 syntheses or guidelines pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Patient-reported outcome measures applied in chronic diseases relevant to asthma remission: a scoping review.European respiratory review : an official journal of the European Respiratory Society · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Future challenges in rheumatology - is telemedicine the solution?Therapeutic advances in musculoskeletal disease · 2022
    Review
  17. Review
  18. COVID-19 illness and autoimmune diseases: recent insights.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2021
    Review
  19. COVID-19: What Do Rheumatologists Need to Know?Current rheumatology reports · 2021
    Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Jatin MistryRheumatology, St George's University Hospitals NHS Foundation Trust, London.
Mohammed SharifRheumatology, St George's University Hospitals NHS Foundation Trust, London.
Amy PrideauxSchool of Medicine, University of Cardiff, Cardiff.
Catherine SmithRheumatology, St George's University Hospitals NHS Foundation Trust, London.
Malama SumbwanyambeRheumatology, St George's University Hospitals NHS Foundation Trust, London.
Margaret SibleyRheumatology, St George's University Hospitals NHS Foundation Trust, London.
Lewis CarpenterDepartment of Inflammation Biology, Institute for Psychiatry, Psychology and Neuroscience, King's College, London.
Melissa SweeneyDepartment of Inflammation Biology, Institute for Psychiatry, Psychology and Neuroscience, King's College, London.
Patrick KielyRheumatology, St George's University Hospitals NHS Foundation Trust, London.ORCID 0000-0002-8091-2717
St George’s University Hospitals NHS Foundation Trust · GBKing's College London · GBCardiff University · GBSt George's, University of London · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe aim was to assess how the patient-reported outcome RA impact of disease (RAID) relates to DAS28 categories in routine care, its utility in identifying patients in DAS28 remission (RDAS) or low disease activity (LDAS) and the burden of unmet patient-reported needs in those achieving RDAS/LDAS.

methodsDAS28 and RAID scores were collected from patients with established RA attending for routine review. The relationship between RAID and DAS28 was assessed with univariate pairwise correlation and mixed-effects linear regression analyses. RAID <2 was defined as a patient-acceptable state.

resultsOne hundred and ninety-eight patients were assessed, with 220 observations, using DAS28-CRP categories: 47.5% RDAS, 14.1% LDAS, 31.8% moderate DAS (MDAS) and 6.6% high DAS (HDAS). Both patient visual analog scale score and tender joint count exhibited a high statistical association with RAID using linear regression (

conclusionRAID functions well as a patient-reported outcome in routine care. Patients with RAID <2 have a high likelihood of being in RDAS/LDAS and, if pre-screened, could avoid a clinic visit. Analysis of RAID domains provides individualized targets for holistic care in RA management, with fatigue and sleep problems dominating unmet needs in those in RDAS/LDAS.

Indexed as

disease activity scorepatient-reported outcomesRAIDrheumatoid arthritis

Identifiers

PMID32685911
PMCPMC7359769
OpenAlexW3019957898

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.